WBI Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Sell
1,084
-1,697
-61% -$469K 0.06% 274
2026
Q1
$821K Buy
+2,781
New +$826K 0.23% 132
2025
Q4
Sell
-1,438
Closed -$389K 327
2025
Q3
$389K Buy
+1,438
New +$391K 0.1% 229
2025
Q1
Sell
-9,240
Closed -$2.15M 241
2024
Q4
$2.15M Buy
+9,240
New +$2.12M 0.54% 54
2016
Q1
Sell
-135,871
Closed -$12.3M 140
2015
Q4
$12.3M Sell
135,871
-339,687
-71% -$32M 0.35% 58
2015
Q3
$44.1M Buy
+475,558
New +$45.2M 1.53% 20

Other funds holding CME

WBI Investments's CME Position: Q2 2026 in Review

WBI Investments reduced its CME Group (CME) stake by 61% in Q2 2026, selling an estimated $469K and leaving 1,084 shares worth $239K. The position accounts for 0.06% of the portfolio, ranked #274.

WBI Investments first reported a position in CME in Q3 2015 and has held it in 6 quarters since. The position peaked at $44.1M in Q3 2015. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • WBI Investments held 1,084 shares of CME Group worth $239K as of Q2 2026.
  • WBI Investments sold 1,697 CME Group shares in Q2 2026, an estimated $469K.
  • CME Group made up 0.06% of WBI Investments's portfolio in Q2 2026, its #274 holding.
  • WBI Investments first reported a position in CME Group in Q3 2015 and has held it in 6 quarters since.
  • WBI Investments's CME Group position peaked at $44.1M in Q3 2015.
  • 1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.